
Venture capital
415 Capital
Munich-based specialist venture firm that invests only in medical technology, concentrating on heart and brain-vessel conditions, in companies from clinical to commercial stage.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is 415 Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
Rounds 415 Capital joined, from press and the firm’s own posts.
Every round 415 Capital joined
Round sizes, 415 Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company 415 Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet 415 Capital
Events where 415 Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
415 Capital is based in München, Germany. It also has an office in Munich. Its registered address is Widenmayerstraße 15, 80538, München.
5 fund vehicles are on public registers (ESMA register), including 415 Capital Fund I GmbH & Co. KG, 415 Capital Fund II GmbH & Co. KG and 415 CAPITAL FUND I GMBH & CO. KG.
Sectors: Medtech. From the firm’s own website.
Targets large unmet needs in chronic disease, chiefly cardiovascular and neurovascular disorders, aiming for better patient outcomes at lower lifetime healthcare cost. Supports device companies from R&D through trials to sales with clinician input, regulatory and reimbursement expertise, and distribution partnerships. Avoids biotech and pharma, healthcare services and wellness products. From the firm’s own website.
€5M to €15M per investment, according to the firm’s own website.
415 Capital lists 34 portfolio companies on its website, including ReEmerge, Endovascular Engineering, Laza Medical, Supira Medical and R3 Vascular.
Firms whose websites list some of the same companies include PANAKES PARTNERS SOCIETA' DI GESTIONE DEL RISPARMIO SPA, Sofinnova Partners and Karista.
Know before 415 Capital’s next round is announced.
PRO tracks 415 Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.